在接受生物制剂治疗的严重喘患者中恶化的表型特征
Hatice Çelik Tuğlu1, Kurtuluş Aksu2, Özgür Akkale1
1University of Health Sciences Atatürk Sanatoryum Training and Research Hospital, Division of Immunology and Allergy, Department of Chest Diseases, Ankara, Turkiye.
Allergologia et immunopathologia
|March 12, 2026
概括
在生物治疗期间识别喘恶化表型至关重要. 在接受奥马利祖马布或梅波利祖马布治疗的患者中,大多数恶化是异敏性,指导未来对严重喘的治疗调整.
科学领域:
- 肺部病理学 肺部病理学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 严重的喘恶化可以被表型化为eosinophilic,neutrophilic或传染性.
- 在生物疗法期间了解恶化现象类型有助于量身定制维持治疗和预防复发.
研究的目的:
- 评估在接受生物药物治疗的患者中喘恶化的临床和表型特征.
主要方法:
- 在16周的生物治疗后,分析了第一个喘恶化.
- 记录了炎症表型,临床特征,白细胞计数,C反应蛋白,季节,抗生素使用和住院.
主要成果:
- 分析了75名接受生物药物 (奥马利祖马布或梅波利祖马布) 的严重喘患者.
- 大多数恶化是异性.
- 奥马利祖马布使用者比梅波利祖马布使用者有显著更高的中等乙酸细胞计数 (p=0.032).
结论:
- 尽管有生物治疗,但喘恶化持续的表型是必不可少的.
- 这种表型指导治疗调整和转换生物药物的决定,以改善患者的治疗结果.
相关概念视频
Asthma-III: Symptoms and Complications
3.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.6K
Asthma-II: Pathophysiology and Classification
4.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.7K
Asthma-I: Introduction
3.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma: Pathogenesis and Management
1.5K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.5K
COPD: Management Using Bronchodilators and Corticosteroids
1.0K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.0K
Asthma-IV: Diagnostic and Management
3.3K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K


